Literature DB >> 10626307

Association between an aggrecan gene polymorphism and lumbar disc degeneration.

Y Kawaguchi1, R Osada, M Kanamori, H Ishihara, K Ohmori, H Matsui, T Kimura.   

Abstract

STUDY
DESIGN: A case-control study using magnetic resonance imaging findings and a polymerase chain reaction assay to investigate the association between aggrecan gene polymorphism and lumbar disc degeneration.
OBJECTIVE: To analyze whether the aggrecan gene polymorphism is related to lumbar disc disease in young women. SUMMARY OF BACKGROUND DATA: It has been suggested that a genetic factor or familial predisposition contributes to the development of lumbar disc herniation. However, the precise genetic component related to disc disease remains unclear. Recently, a polymorphism has been identified in the region of the human aggrecan gene. The expressed variable numbers of tandem repeat polymorphism occur in the highly conserved repeat region.
METHODS: The participants were 64 young women with or without low back problems. Magnetic resonance imaging was used to evaluate the degeneration and herniation of the intervertebral disc. Genomic deoxyribonucleic acid was extracted from all participants. A polymerase chain reaction assay was carried out to detect the alleles of the aggrecan gene. The association of intervertebral disc degeneration and herniation with the distribution of the aggrecan gene alleles was analyzed.
RESULTS: Findings showed an overrepresentation of alleles with small numbers of repeats in subjects with multilevel disc degeneration, thus indicating a significant distribution difference. There also was a significant difference between the distribution of alleles and the severity of disc degeneration. No significant association was found between any of the alleles either in number or type of disc herniation.
CONCLUSIONS: The current study showed that multilevel and severe disc degeneration was present in the participants with shorter variable numbers of tandem repeat length of the aggrecan gene. This suggests that subjects with shorter variable numbers of tandem repeat length of the aggrecan gene have a risk of having multilevel disc degeneration develop at an early age.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626307     DOI: 10.1097/00007632-199912010-00006

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  42 in total

1.  Genetic mapping of a susceptibility locus for disc herniation and spastic paraplegia on 6q23.3-q24.1.

Authors:  M Zortea; A Vettori; C P Trevisan; S Bellini; G Vazza; M Armani; A Simonati; M L Mostacciuolo
Journal:  J Med Genet       Date:  2002-06       Impact factor: 6.318

2.  The postnatal role of Sox9 in cartilage.

Authors:  Stephen P Henry; Shoudan Liang; Kadir C Akdemir; Benoit de Crombrugghe
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

3.  Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease.

Authors:  Yasuyuki Nobuhara; Koichiro Usuku; Mineki Saito; Shuji Izumo; Kimiyoshi Arimura; Charles R M Bangham; Mitsuhiro Osame
Journal:  Immunogenetics       Date:  2006-01-10       Impact factor: 2.846

4.  A functional polymorphism in COL11A1, which encodes the alpha 1 chain of type XI collagen, is associated with susceptibility to lumbar disc herniation.

Authors:  Futoshi Mio; Kazuhiro Chiba; Yuichiro Hirose; Yoshiharu Kawaguchi; Yasuo Mikami; Takeshi Oya; Masaki Mori; Michihiro Kamata; Morio Matsumoto; Kouichi Ozaki; Toshihiro Tanaka; Atsushi Takahashi; Toshikazu Kubo; Tomoatsu Kimura; Yoshiaki Toyama; Shiro Ikegawa
Journal:  Am J Hum Genet       Date:  2007-10-16       Impact factor: 11.025

Review 5.  Schmorl's nodes: current pathophysiological, diagnostic, and therapeutic paradigms.

Authors:  Tobias A Mattei; Azeem A Rehman
Journal:  Neurosurg Rev       Date:  2013-08-18       Impact factor: 3.042

Review 6.  Genetics of disc degeneration.

Authors:  Danny Chan; Youqiang Song; Pak Sham; Kenneth M C Cheung
Journal:  Eur Spine J       Date:  2006-07-04       Impact factor: 3.134

7.  The potential value of blood biomarkers of intervertebral disk metabolism in the follow-up of patients with sciatica.

Authors:  Federico Balagué; Margareta Nordin; Dominique Schafer; Ali Sheikhzadeh; Mary Ellen Lenz; Eugene M A Thonar
Journal:  Eur Spine J       Date:  2005-07-01       Impact factor: 3.134

Review 8.  Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data.

Authors:  Thomas S W Park; Andy Kuo; Maree T Smith
Journal:  Inflammopharmacology       Date:  2018-05-12       Impact factor: 4.473

Review 9.  Genetic polymorphisms associated with intervertebral disc degeneration.

Authors:  Jillian E Mayer; James C Iatridis; Danny Chan; Sheeraz A Qureshi; Omri Gottesman; Andrew C Hecht
Journal:  Spine J       Date:  2013-03       Impact factor: 4.166

10.  Pharmacological enhancement of disc diffusion and differentiation of healthy, ageing and degenerated discs : Results from in-vivo serial post-contrast MRI studies in 365 human lumbar discs.

Authors:  S Rajasekaran; K Venkatadass; J Naresh Babu; K Ganesh; Ajoy P Shetty
Journal:  Eur Spine J       Date:  2008-03-21       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.